These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17062380)

  • 1. Phenotypic and genotypic heterogeneity in transthyretin-related cardiac amyloidosis: towards tailoring of therapeutic strategies?
    Rapezzi C; Perugini E; Salvi F; Grigioni F; Riva L; Cooke RM; Ferlini A; Rimessi P; Bacchi-Reggiani L; Ciliberti P; Pastorelli F; Leone O; Bartolomei I; Pinna AD; Arpesella G; Branzi A
    Amyloid; 2006 Sep; 13(3):143-53. PubMed ID: 17062380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
    Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
    Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.
    Rapezzi C; Quarta CC; Obici L; Perfetto F; Longhi S; Salvi F; Biagini E; Lorenzini M; Grigioni F; Leone O; Cappelli F; Palladini G; Rimessi P; Ferlini A; Arpesella G; Pinna AD; Merlini G; Perlini S
    Eur Heart J; 2013 Feb; 34(7):520-8. PubMed ID: 22745357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis.
    Rapezzi C; Quarta CC; Guidalotti PL; Pettinato C; Fanti S; Leone O; Ferlini A; Longhi S; Lorenzini M; Reggiani LB; Gagliardi C; Gallo P; Villani C; Salvi F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):659-70. PubMed ID: 21679902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver transplantation for hereditary transthyretin amyloidosis.
    Suhr OB; Herlenius G; Friman S; Ericzon BG
    Liver Transpl; 2000 May; 6(3):263-76. PubMed ID: 10827225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
    Lobato L
    J Nephrol; 2003; 16(3):438-42. PubMed ID: 12832749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of homozygosity for an amyloidogenic transthyretin mutation on phenotype and long term outcome.
    Holmgren G; Hellman U; Lundgren HE; Sandgren O; Suhr OB
    J Med Genet; 2005 Dec; 42(12):953-6. PubMed ID: 15930086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre.
    Caponetti AG; Sguazzotti M; Accietto A; Saturi G; Ponziani A; Giovannetti A; Massa P; Ruotolo I; Sena G; Zaccaro A; Parisi V; Bonfiglioli R; Guaraldi P; Gagliardi C; Cortelli P; Galie N; Biagini E; Longhi S
    Eur J Prev Cardiol; 2024 May; 31(7):866-876. PubMed ID: 38204330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
    Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
    Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS.
    Gentile L; Tournev I; Amass L; Chapman D; Mazzeo A;
    Cardiol Ther; 2021 Dec; 10(2):481-490. PubMed ID: 34148211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
    Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
    J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
    Augustin S; Llige D; Andreu A; González A; Genescà J
    Eur J Clin Invest; 2007 Aug; 37(8):673-8. PubMed ID: 17635579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.
    Bauer R; Dikow N; Brauer A; Kreuter M; Buss S; Evers C; Röcken C; Schnabel PA; Hinderhofer K; Ehlermann P; Katus HA; Kristen AV
    Amyloid; 2014 Dec; 21(4):267-75. PubMed ID: 25291558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transthyretin mutations in health and disease.
    Saraiva MJ
    Hum Mutat; 1995; 5(3):191-6. PubMed ID: 7599630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac involvement in hereditary-transthyretin related amyloidosis.
    Rapezzi C; Longhi S; Milandri A; Lorenzini M; Gagliardi C; Gallelli I; Leone O; Quarta CC
    Amyloid; 2012 Jun; 19 Suppl 1():16-21. PubMed ID: 22494034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined heart and liver transplantation in four adults with familial amyloidosis: experience of a single center.
    Nardo B; Beltempo P; Bertelli R; Montalti R; Vivarelli M; Cescon M; Grazi GL; Salvi F; Magelli C; Grigioni F; Arpesella G; Martinelli G; Cavallari A
    Transplant Proc; 2004 Apr; 36(3):645-7. PubMed ID: 15110620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asp58Ala is the predominant mutation of the TTR gene in Korean patients with hereditary transthyretin-related amyloidosis.
    Jang MA; Lee GY; Kim K; Kim SJ; Kim JS; Lee SY; Kim HJ; Jeon ES
    Ann Hum Genet; 2015 Mar; 79(2):99-107. PubMed ID: 25644864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants.
    Holmgren G; Hellman U; Anan I; Lundgren HE; Jonasson J; Stafberg C; Fahoum S; Suhr OB
    Amyloid; 2005 Sep; 12(3):184-8. PubMed ID: 16194874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.